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late life extends lifespan of Balb/c mice with
differential effects on DNA damage
Scott A Nankervis1, Jenee M Mitchell1, Fadi J Charchar1, Maree A McGlynn2 and Paul A Lewandowski2*Abstract
Background: Caloric restriction is known to extend the lifespan of all organisms in which it has been tested.
Consequently, current research is investigating the role of various foods to improve health and lifespan. The role of
various diets has received less attention however, and in some cases may have more capacity to improve health
and longevity than specific foods alone. We examined the benefits to longevity of a low glycaemic index (GI) diet
in aged Balb/c mice and examined markers of oxidative stress and subsequent effects on telomere dynamics.
Results: In an aged population of mice, a low GI diet extended average lifespan by 12%, improved glucose
tolerance and had impressive effects on amelioration of oxidative damage to DNA in white blood cells. Telomere
length in quadriceps muscle showed no improvement in the dieted group, nor was telomerase reactivated.
Conclusion: The beneficial effects of a low GI diet are evident from the current study and although the impact to
telomere dynamics late in life is minimal, we expect that earlier intervention with a low GI diet would provide
significant improvement in health and longevity with associated effects to telomere homeostasis.Background
Caloric restriction (CR) has positive effects on both mean
and maximum lifespan [1-4], and since the original report
the lifespan and health-span increasing capabilities of CR
have been documented in a range of animals ranging from
yeast to flies and mammals [2,5]. These studies indicate that
CR-induced increases in animal longevity are accompanied
by decreased morbidity from a range of age-related diseases
such as cardiac and cardiovascular disease, autoimmune
disease, cancer, diabetes and renal, respiratory and neural
diseases [2,6,7]. Furthermore, CR has also been implicated
in stress resistance responses [7,8]. The most potent
example of a form of CR is dietary methionine restriction
which has been documented to increase lifespan by 45% in
F344 mice [8,9], while protein restriction yields an average
20% lifespan increase in mice and rats [2,3,9]. It is now
clearly evident that diet plays a crucial role in health
and longevity, and unraveling the active interacting
components of diet and ageing could have positive
ramifications worldwide.* Correspondence: paul.lewandowski@deakin.edu.au
2School of Medicine, Deakin University, Geelong, Vic 3217, Australia
Full list of author information is available at the end of the article
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reproduction in any medium, provided the orTelomere length decrease has emerged as a potential
marker of biological ageing [2,10] and the overarching idea
suggests that telomeres protect the ends of chromosomes
from replicative loss; the unavoidable shortening of chro-
mosomes that occurs with successive rounds of division
eventually leads to chromosomal damage, at which point
the cell enters a state of irreversible senescence [10]. The
combination of dynamic telomeres with the lifespan-
increasing capabilities of CR and dietary restriction (DR),
have made telomeres an important target for longevity
research. In dissecting various contributors to the success
of CR and DR, researchers have become aware of the
ability to influence telomere length maintenance and fluc-
tuation with the provision and/or restriction of certain
foods. In a large study of individuals on a range of dietary
patterns, Nettleton et al. [7,11] did not identify significant
impacts to leukocyte telomere length in any of a range of
foods studied, except for processed meat which showed a
negative correlation with telomere length with increasing
intake. In a health study using only female participants,
dietary fibre was identified as having a positive association
with leukocyte telomere length [8,12], while chronic
DR (defined here as restricted eating due to chronicral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
01
2
3
4
5
6
7
8
0 30 60 90 120
Time (minutes)
G
lu
co
se
 (m
m
o
l/L
)
Glycaemic Index of Test Diets
Figure 1 Glycaemic index of the experimental diets. Plasma
glucose after ingestion of 500 mg of experimental diets. Asterixes
indicate significant difference in blood glucose concentration at
each measured interval (P <0.05). Error bars show SEM. Solid line
with triangular markers (-▲ -) denotes control group, perforated line
with square markers (-- ■ --) denotes low GI group.
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telomere length in a female cohort [8,9,13]. In men placed
on CR diets, O’Callaghan et al. [10,14] observed midrectal
mucosa telomere length gain with increasing weight loss
over a 12-month period; the more weight lost, the greater
the increase in telomere length. Studies on the effect of
lifelong CR on rhesus monkeys have reported an increase
in longevity for CR animals [11,15], however this is not
associated with CR-induced alterations to skeletal muscle
telomere length [1,12] and may be an artifact of husbandry
and study design rather than CR itself [5,13]. Work by
Wang et al. [6] in which mice were placed on short-term
(3-month) CR programs revealed improvements to telo-
mere length maintenance without increases in telomerase
activity in the small intestine, and reduced frequency of
senescent intestinal enterocytes and liver hepatocytes.
Evidence to date certainly indicates beneficial effects of
CR/DR programs to both longevity and telomere length.
It is apparent that one of the contributing factors to
improved longevity and telomere length on a CR or DR
program that decreases caloric intake is that of reduced
oxidative stress through decreases in steady-state oxidant
levels; oxidative damage is believed to be a key factor caus-
ing senescence [7,15]. A number of studies have shown a
link between CR and decreased production of reactive
oxygen species (ROS) [3,4,6,7,16,17], and oxidative damage
to DNA (oxidised bases, abasic sites and single- and
double-strand breaks) increases with ageing in mammalian
tissues [3,4,18]. Additionally, DR has been shown to
decrease cumulative markers of oxidative stress in intestine
and liver of mice and contributes to a decrease in cellular
senescence [2,6]. The link between oxidative stress and
telomere shortening specifically is now well established.
Von Zglinicki et al. [19] reported reductions in telomere
length in human fibroblasts exposed to oxidative stress,
and that this loss results in telomere-driven replicative
senescence as a stress response. Telomere shortening was
also observed after oxidative stress induction in a variety of
tissues in mice [7,20]. The oxidative damage to telomeres
has been localised specifically to the GGG triplet of the
telomeric repeat [8,21,22] and it has been made apparent
that telomeres are particularly susceptible to damage
caused by oxidative stress. Components of the protective
shelterin complex of telomeres (such as TRF2) prevent
access by DNA damage repair (DDR) mechanisms and this
induces persistent DDR, markers of which are evident in
telomeres that are not critically short in terminally differ-
entiated cells [23,24]. The susceptibility to damage and the
inability to repair induces cellular senescence, and this can
occur independently of telomere length [23,24]. It is now
apparent that although telomere length is a critical factor
in ageing, exogenous forms of stress acting specifically on
telomeres are also a crucial in this regard and can induce
senescence without telomere shortening.CR (and DR) is clearly linked to beneficial improvements
in health and longevity in animals and humans [2,9].
Telomeres prevent cellular senescence occurring as a con-
sequence of DNA damage such as occurs via oxidative
stress, and dietary factors are known to prevent ROS accu-
mulation. Due to the links among telomeres, oxidative
stress and dietary intake, the impact of diet on telomere
biology and ageing is an important area only now beginning
to receive attention. This is certainly apparent in the associ-
ations between glycaemic index (GI) and oxidative stress.
Chronic hyperglycaemia is correlated with increased
production of free radicals and depletion of antioxidants in
patients with type 2 diabetes [10,25], and positive associa-
tions with markers of oxidative stress were observed with
elevated glycated haemoglobin and blood glucose concen-
tration in patients with well-controlled type 2 diabetes
[11,26]. In the present study, we examined the impact of a
low GI diet on ageing mice, examining markers of health
and longevity and their consequent impacts on aspects of
telomere biology.
Results
Glycaemic index of the test diets
After the training period, eight animals in each group con-
sumed the entire test meals from each diet. Differences
for glucose at single time points are shown in Figure 1.
The low GI diet resulted in significantly lower blood
glucose at all time points except for baseline (P <0.05).
Lifespan
A Kaplan-Meier plot of mouse survival (Figure 2)
indicates the survival rates of control and low GI
mice until termination of the study. The low GI diet
intervention started at 90 weeks (20 months old).
Figure 2 Lifespan of control and low GI mice. The low GI
intervention commenced at week 90 (20 months old, arrow). Solid line
(-) denotes control group, perforated line (- -) denotes low GI diet group.
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between control (95 weeks) and low GI (106.7 weeks)
groups (P = 0.00003), that represented an increase of
approximately 12% in lifespan for animals on a low
GI diet. Approximately 25% of the original population
died before 90 weeks, indicative of the aged status of
this population prior to intervention and showing that
a low GI diet significantly extended the lifespan of
animals that had already entered old age.
Body weight and body weight to muscle ratios
Mouse body weight was recorded as the average body
weight of all animals each week over the course of the
study and is shown in Figure 3. Expectedly, body weight
increased to maturity and declined with ageing; body
weight of the low GI mice continued to decline into
extreme old age until the weight of the last remainingFigure 3 Average body weight measurements per week for all anima
beginning of low GI intervention for the experimental group. Black diamonanimals nears values seen for the 6-month-old mice.
Average body weight increased steadily until maximum
average body weight was attained at week 62 and
reached 29.5 g ± 0.25 SEM. Average body weight was
maintained consistently until approximately week 85
and began to decline as mortality increased (Figure 2).
Low GI intervention was begun on a subset of animals
at week 90 and separate average weights calculated for
this group beginning at week 91. Average body weight
increased at this time point due to the deaths of some of
the comparatively underweight individuals (data not
shown) that increased the average, but this smoothed
out from week 93 onwards until week 109 where this
phenomenon was seen again. Week 110 marks the death
of the final control animals and body weight becomes
consistent again amongst the low GI population until
the conclusion of the study with the death of the last
remaining animals.
Food and water consumption
The average quantity of food consumed increased at 18
months of age, and then declined and remained steady
(Figure 4A). There was no difference in food quan-
tity consumed between control and low GI animals
at 24 months of age. Average water intake rose
steadily with age until 18 months of age, and then
decreased dramatically with increasing age afterwards
(Figure 4B). Significant decreases in intake were
observed between 18- and 20-month-old animals and
18- and 24-month-old animals, however there was
no observed difference in intake between 24-month-old
control and low GI populations.
Intraperitoneal glucose tolerance test
The glucose tolerance of mice was measured to assess
the physiological impact of a low GI diet intervention inls measured until mortality. Vertical line at week 90 indicates
ds (♦) denote control group, gray circles (•) denote low GI group.
Figure 4 Average food and water intake. (A) Average food intake for all animals (n = 8 for each group); a significant increase in consumption
was observed in 18-month-old animals; black bars indicate control groups, gray bars indicate low GI group; (B) Average water intake for all
animals (n = 8 for each group); significant decreases in consumption were observed with age from 18 months old onwards. For both (A) and (B),
each age group has been designated a to f, and significant differences for each age group compared to other age groups are indicated above
the SEM, for example, cd indicates that group c (18 months old) is significantly different to group d (20 months old); black bars indicate control
groups, gray bars indicate low GI group.
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age groups in resting blood glucose concentration prior
to glucose injection (t = 0), from 30 min onwards we
observed consistent significantly elevated blood glucose
concentration with age with the exception of younger
mice (6 and 12 months old) in which there was no
difference in glucose clearance rate after injection.
In the control or low GI groups at 24 months old we
observed either increases or no difference in blood
glucose concentration in the older animals compared to
other age groups (Figure 5B). Interestingly, for the most
part there appears to be consistent reductions in bloodglucose concentration in 24-month-old low GI mice in
comparison to other age groups, while the control counter-
parts consistently show increased blood glucose concentra-
tion in comparison to all other age groups. Furthermore,
while the 24-month-old control and low GI mice had simi-
lar (though significantly different) resting and end-point
blood glucose concentrations, there were significant diffe-
rences at 30 (P <0.0001) and 45 (P = <0.0001) min post
injection which reflect a much greater capability of the low
GI mice to tolerate blood glucose fluctuation.
We calculated the area under the curve (AUC) for
each age group (Figure 6). It is apparent from the data
Figure 5 Blood glucose tolerance. (A) Intraperitoneal glucose tolerance measured in mmol/L over a period of 90 min in 6- to 20-month-old
control mice (n = 16 each group); numbers above data points at each time interval indicate significant differences according to the following
scheme: 1, 6mo vs. 12mo; 2, 6mo vs. 18mo; 3, 6mo vs. 20mo; 4, 12mo vs. 18mo; 5, 12mo vs. 20mo; 6, 18mo vs. 20mo. Error bars show SEM. Solid
line () denotes 6mo group, while perforated lines from longest to smallest denote 12 (- -), 18 (- - -) and 20mo (. . .) controls respectively. (B)
Intraperitoneal glucose tolerance measured in mmol/L over a period of 90 min in 24-month-old control and low GI diet mice (n = 8 each group).
Asterixes indicate significant difference in blood glucose concentration at each measured interval (P <0.05). Error bars show SEM. Solid line with
triangular markers (-▲ -) denotes control group, perforated line with square markers (- -■--) denotes low GI group.
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erance with a steady significant increase in AUC up to
the 20-month-old time point, reflecting age-related glu-
cose intolerance. Surprisingly, the 24-month-old control
mice show a similar AUC value to 18-month-old animals
(no significant difference; P = 0.2), while the 24-
month-old low GI group has an AUC value similar to
mice between 6 and 12 months old (no significant
difference to 6 months old, P = 0.75, or 12 months old,P = 0.3). The difference between 24-month-old control
and low GI groups is significant with a decrease in AUC
for the low GI group, reflecting greater glucose tolerance
(P = 0.004).
Oxidative stress
Aged mice have significantly reduced markers of oxida-
tive stress after intervention with a low GI diet (Figure 7),
as measured by frequency of abasic DNA sites and
Figure 6 Area under curve measured for IPGTT in all mice age groups. Each bar is designated a to f, and all corresponding significant
differences are indicated above each bar (P <0.05), for example ab indicates that group A (6 months old) is significantly different to group B (12 months
old); black bars indicate control groups, gray bars indicate low GI group, (n = 16 for 6- to 20-month-old groups, n = 8 for 24-month-old groups).
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from WBCs. We observed significant increases in these
two markers of oxidative stress between 20 and 24
months old in the control population (abasic P = 0.007,
8-OH-2dG P = 0.01), but this increase was ameliorated
in the low GI intervention group to the point that abasic
frequency and 8-OH-2dG levels remained steady from
20 months old onward. There was also a significant dif-
ference between control and low GI groups at 24
months old (abasic P = 0.002, 8-OH-2dG P = 0.001),
with greater levels of oxidative stress as indicated by
both markers observed in the control group.
Telomere length
Since dietary regime is known to influence telomere
length homeostasis [1,6,12-15], we measured average
quadriceps muscle telomere length of all mice up to 20
months old, and in both the control and low GI diet
groups (Figure 8). The variability of the data at the
12-month-old and 20-month-old groups is evident for
these time points, however this variability is decreased
by 24 months. There was no significant difference
found in quadriceps muscle irrespective of the reference
point used, however there does appear to be a trend in
declining telomere length with age that is possibly
reversed with a low GI diet.
mTERT gene expression
As a marker of telomere dynamics additional to length
change, we measured the gene expression of mTERT
(rate limiting component of telomerase) in mouse quad-
riceps. The expression of mTERT was not detectableuntil 24 months of age, and was inconsistently detected
(data not shown).
Discussion
Lifespan extension via CR is well documented in the
literature [14,27], and there is evidence implicating
DR, specifically protein restriction, with lifespan extension
as well [8,9,15]. Often, studies examining CR or DR also
find changes in telomere length, commonly used as a
marker of biological ageing [1,6,12-15]. We have
observed lifespan extension of aged mice placed on a
low GI diet, yet did not find any associated changes
to telomere length.
The effect of a CR diet on longevity is wholly
dependent on the point in the life of the organism at
which the regime is started [5,28]. Bearing this in mind,
the present study is limited in reporting the extent to
which a low GI diet can positively affect mouse longe-
vity; however at even such a late stage in life, we were
able to significantly extend the average lifespan of aged
mice through a low GI diet alone by 12%. In studies
examining the effect of lifetime CR, mice fed a slightly
restricted calorie diet showed a 13% increase in lifespan
compared to ad libitum controls [6,29], while CR has
been used in 19-month-old mice to extend mean time to
death by 42%, and increase both mean and maximal life-
span [7,30]; 34% increase in lifespan [3,6,7,16,17] and a
negative correlation observed between caloric intake and
average lifespan [31] has also been reported. So while
the evidence supporting the life-extending capability of
CR is apparent, it appears from the present study that a
low GI diet can be similarly potent. The average lifespan
Figure 7 Markers of oxidative stress in control versus low GI mice. (A) Abasic DNA sites were identified in both control mice and the low GI
group mice at each time interval and data shown are number of abasic sites per 100,000 base pairs (bp) (n = 16 for 6- to 20-month-old animals,
n = 8 for 24-month-old animals); * indicates significant difference between 20-month-old control versus 24-month-old control, ** indicates
significant difference between 24-month-old control versus 24-month low GI (P <0.05); solid line () denotes control, perforated line (- - -) denotes
low GI. (B) Levels of 8-OH-2dG formation in DNA in both control mice and low GI mice at each time interval, data shown are pg/mL of 8-OH-2dG
formed (n = 16 for 6- to 20-month-old animals, n = 8 for 24-month-old animals); * indicates significant difference between 20-month-old control
versus 24-month-old control, ** indicates significant difference between 24-month-old control versus 24-month low GI (P <0.05); solid line () denotes
control, perforated line (- - -) denotes low GI.
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week (20 months) intervention point is after approxi-
mately 95% of life lived which is well in excess of the
calculations (for humans) provided by Speakman and
Hambly [28]. This suggests that there would effectively
be no beneficial impact of a CR diet at this point in the
animals’ life, which agrees with Lipman et al. [32]. It is
of interest then that our use of a low GI diet hasproduced a 12% increase in lifespan from late-life (90
weeks) which is later than predictions [28] and other
studies [30] have produced with CR. This suggests that
the use of a low GI diet from earlier in life has the
potential to elicit even greater lifespan effects and
warrants further investigation.
Lifetime body weight fluctuation in mice typically
increases over the first 12 months, and then plateaus
Figure 8 Relative telomere lengths of mice. Data for 12-month-old mice were normalised to 1, and the telomere lengths for other age groups
were calculated relative to the 12-month-old group. No significant differences were observed between any of the groups, (n = 6, 8, 7 and 7 for
the 12, 20, 24 and low GI groups, respectively).
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the first 12 months (approximately 60 weeks old), which
plateaus until week 85 and begins to steadily decline
with age, unlike the mice or rats in the aforementioned
studies but somewhat similar to Masoro et al. [34]. The
calculated quadriceps muscle to body weight ratio
(Figure 3) confirm the rapid growth from 6 to 12
months old with a sharp decline at 18 months that plat-
eaued for the remainder of the study, and this agrees
well with the literature [3,29,33]. This decline may indi-
cate that the mice in our present study behaved physio-
logically as other rodents do, but without weight
maintenance (based on continuous weight decline with
age: Figure 2); this could be explained by fat composition
in the diet (Table 1), however this is not reported in the
Weindruch [29] or Alemaan [33] studies. Typically, CR
results in reduced body fat (reviewed in [27]) which
would produce a divergence in body weights of ad
libitum versus CR animals over time; since our interven-
tion was late in life, there is unlikely to have been suffi-
cient time to observe noticeable differences in body
weight in the present study. Once this factor is removed,
the decline in weight with age is probably attributable to
decreased muscle mass, a phenomenon known as
sarcopenia which is typical in ageing animals [35]; how-
ever even this is seen to be reduced in rats [36] and
monkeys [37] on a CR diet.
There is a clear relationship between food intake and
body weight (Figures 2 and 9A). Food intake continu-
ously increased up to 18 months of age, whereafter it de-
creased, and the change in body weight over time
reflects this food intake with a decline with increasingage after 18 months. Our observation of similar food
intake between control and low GI groups is in contrast
to the increases observed in low GI animals [38]. When
comparing water intake in the low GI and control
groups there was no difference in consumption however
we observed a downward trend in water consumption
with age. Elderly humans are known to have decreased
thirst sensitivity [39,40], and this phenomenon seems a
possibility in our mice since in old age mouse body
weight approximated those of the 6-month-old measure-
ments and food intake did not change, yet decreased
water intake was observed. This however could also be
the result of activity levels, which we did not record,
typically being higher in younger animals (and requiring
more water) and declining with age.
Decreased glucose tolerance is a hallmark of both dia-
betes mellitus [41] and ageing [42]. Reflecting this as a
consequence of ageing, we observed a steady decline in
glucose tolerance with age in mice until 20 months old,
after which tolerance began to increase slightly (and
significantly) in the 24-month-old controls and then
returning to tolerance levels observed in 18-month-old
animals, while those on a low GI diet had their glucose
tolerance improve to levels observed at 6 months of age
(Figure 5). The response of the low GI animals in the
present study is likely similar to the concomitant
increases in insulin sensitivity that have been observed
in rats undergoing CR [43] and on low GI diets as
evidenced by smaller area under curve for blood glucose
and plasma insulin after oral glucose challenge [38].
Therefore, as glucose intake is reduced (as in low GI
diet), the animal becomes more sensitive to the effects
Table 1 Diet composition
Ingredients Low GIa Controlb
Digestible energy (MJ/kg) 13.5 14.0
Protein (%) 19.7 20.0
Fat (%) 5.0 4.8
Crude fibre (%) 6.4 4.8
Valine (%) 1.40 0.87
Leucine (%) 0.88 1.40
Isoleucine (%) 1.40 0.80
Threonine (%) 0.80 0.70
Methionine (%) 0.23 0.30
Cystine (%) 0.31 0.30
Lysine (%) 1.00 0.90
Phenylalanine (%) 0.90 0.90
Tyrosine (%) 0.7 0.50
Tryptophan (%) 0.20 0.20
Total monounsaturated fats (%) 1.47 2.00
Total polyunsaturated fats (%) 1.72 1.77
Total saturated fats (%) 0.45 0.74
Mineral mix S10001 (g/kg) 35 35
Vitamin mix V10001 (g/kg) 10 10
Glycaemic index (vs. glucose) 27 70
aA fixed formula ration including barley, lupins, canola oil, safflower (high
linoleic) oil, dicalcium phosphate, magnesium oxide, calcium carbonate, salt,
sulphur, fish meal, soya bean meal, vitamin premix and mineral premix. Diet
was primarily based on barley and designed to reduce GI using published data
on raw materials used.
bA fixed formula ration including wheat, barley, lupins, soya meal, fish-meal,
mixed vegetable oils, canola oil, salt, calcium carbonate, dicalcium phosphate,
magnesium oxide, vitamin premix and mineral premix. Diet was primarily
based on wheat with GI determined using published data on raw
materials used.
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difficult to reconcile the improvement in glucose tole-
rance in the 24-month-old controls, particularly when
food consumption did not decrease. Based on the steady,
sharp decline in water intake from 18 months onwards
it is possible that thirst sensitivity declined with age and
the subsequent hypovolemia may have increased circu-
lating insulin concentration which improved glucose
tolerance transiently; the further significant increase in
glucose tolerance seen in low GI animals could be the
result of both decreased thirst sensitivity and improved
insulin sensitivity.
The link between age-related mortality and increases
in oxidative stress have been documented well and in
particular the effect of a CR regime in mammals is
shown to reduce oxidative stress and increase lifespan
[7,16,44]. It has been suggested that oxidative stress is
linked to mortality with a negative correlation between
specific metabolic function (greater in smaller animals)
and life span [45] - increased oxygen consumption tosupport increased metabolism exposes the organism to
higher quantities of oxidants [46,47]. We have demon-
strated a potential link between low GI diet and lifespan
with oxidative stress as an intermediate (as measured by
number of abasic sites and formation of 8-OH-2dG)
(Figure 6) in the present study. Furthermore while the
current study focused on oxidative to DNA it is conceiv-
able that a low GI diet may reduce other biomarkers of
oxidative stress, including glutathione, malondialdehyde
and protein carbonyls. The effect of oxidative stress
appears to be particularly pronounced in telomeric
versus non-telomeric sequence, specifically the GGG
triplet, and this focus of oxidative damage may be
important in age-related telomere shortening [21,48], or
early senescence without shortening [23,24]. Associa-
tions between telomere length and ageing were first
made apparent by Cawthon et al. [49] with shorter telo-
meres contributing to greater all-cause mortality. Fol-
lowing this, other groups reported findings of shortened
telomeres contributing to early mortality and/or cellular
senescence [50-52]. Subsequently, the causes of telomere
shortening, in addition to cellular division, have become
a point of interest and include genetics, oxidative stress,
inflammation and psychological/life stress [10]. The cap-
acity for muscle telomere length to reflect environmental
damage to myocytes has been indicated by Ahmad et al.
[53] in a type-2 diabetes setting and is preferentially used
over white blood cell leukocyte telomere length. In the
context of our present study, placement on a low GI diet
impacted glucose tolerance and therefore glucose metab-
olism; therefore we reasoned that measurement of
muscle telomere length reported by Ahmad et al. [53]
was an appropriate experimental approach. Furthermore,
recent studies are revealing that skeletal muscle has far
greater capacity for telomere regulatory mechanisms
than previously realised [54-58]. While we observed a
downward trend in telomere length in mice overtime, we
did not observe any significant differences over the course
of this trend. It is clear from Figure 7 that there was great
inter-individual variation in telomere length in mice up to
20 months old, and this is in fact supported in the litera-
ture [59]. The inter-individual variability is also known to
decline with age [60], an effect we have seen in the present
study. Whether the apparent, slight non-significant
increase in telomere length in the 24-month-old low GI
group is a trend could be determined with earlier inter-
vention with a low GI diet. It is possible that in combi-
nation with the reduction in markers of oxidative stress in
low GI animals that continued telomere length measure-
ment in this group might indicate telomere length main-
tenance and/or slowed progression of shortening while
control animals continue to decline. However, with the
most recent advances in understanding the effects of oxi-
dative stress-induced damage to telomeres we cannot rule
Figure 9 Muscle to body weight ratios for ageing mice. Average quadriceps muscle to body weight ratio (n = 8 for each age group). One-
way ANOVA indicated significance among the groups (P <0.001). An asterisk indicates a significant difference between the 6-month-old group
and every other group except 18 months old (P <0.05); two asterisks indicate a significant difference between the 12-month-old group and every
other group (P <0.05).
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factor here, but could instead be early senescence caused
by irreparable DNA damage [23,24] which is attenuated by
reduced oxidative stress in the low GI group.
To tease out changes to telomere dynamics with inter-
vention using a low GI diet, we measured the gene expres-
sion of mTERT, the subunit of telomerase responsible for
telomere lengthening. Telomerase activity is known to in-
crease with intensive lifestyle intervention (which included
diet) [61], however the majority of human cells have no
detectable telomerase activity [62]. Telomerase is
transcriptionally regulated [62] and so TERT is a good
proxy for the detection of resumption of telomere length-
ening in adult cells. The lack of consistent mTERT gene
expression in mouse quadriceps indicates that in this tis-
sue a low GI diet failed to reactivate telomerase gene
expression, and therefore appreciable telomere lengthen-
ing and/or length homeostasis did not occur via this
mechanism. Combined with the observed lack of telomere
lengthening in GI-dieted animals, a lack of mTERT detec-
tion suggests that any role a low GI diet may have at the
telomere level in lifespan extension may be through length
maintenance instead.
Conclusions
The present study has identified the potential benefit of
a low GI diet to increase lifespan. Compellingly, we were
able to extend mouse lifespan from a very late interven-
tion point suggesting that a long-term regime could be a
very powerful agent for longer, healthier life. The most
direct indication of low GI impact was in markers ofoxidative stress that were significantly decreased at 24
months of age in the low GI diet group. We did not
observe significant alterations to telomere length but did
observe a slow decline with age, nor did we observe
changes in TRF2 gene expression indicating that
protective mechanisms were not altered at this level over
the course of the study. The relevance of the findings to
humans would still needs to be tested. However it is
possible to speculate that consumption of a low GI diet
late in life still has beneficial health effects and it may
extend lifespan, although the effect may not be as dra-
matic as an intervention earlier in life. The extension of
life may not represent a significant number of years lived
but rather an improved quality of life or healthspan.
Availability of supporting data
The data set supporting the results of this article is
included within the article.
Methods
Animal model of ageing and low GI diet supplementation
All animal procedures carried out in this study were
approved by the Deakin University animal welfare com-
mittee (A37/2007). Four-week-old female Balb/c mice
(n=70) were assigned to five groups: 6, 12, 18, 24 months
and a group that would be allowed to achieve their natural
lifespan. Mice were housed in groups of up to eight
animals per box and maintained under controlled envi-
ronmental conditions; 12-h light/dark cycle, 21 ± 2°C,
30% humidity, in conventional cages with ad libitum
access to standard chow (Table 1, Specialty Feeds) and
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the 24-month group and mice that were still alive in the
life span group were allocated to receive ad libitum access
to a low GI chow and water (n=32, Table 1, Specialty
Feeds) or continued with ad libitum access to standard
chow and water (n=32) for the remainder of the study.
Animal body weights, food intake and water consumption
were measured once a week, while the health of the
animals was monitored daily. Twenty months of age was
estimated to be equivalent to a human age of 75 years
based on an average lifespan of 21.1 months in mice being
equivalent to a human lifespan of 85 years. Animal life
span was determined based on mice being found dead in
their cage or being euthanised for animal welfare purposes.
At 6 (n=16), 12 (n=18), 18 (n=12) and 24 (n=12) months
mice were anaesthetised via intra-peritoneal injection with
lethabarb (50 mg/kg), then blood and skeletal muscle
tissues were collected and immediately snap frozen in
liquid nitrogen and stored at -80°C for later use.
Glycaemic index of the test diets
In addition to the main experiments, postprandial glucose
responses to the low GI and control diets were tested in a
separate group of 12-week-old female Balb/c mice (n=8 for
each diet). In order to achieve comparable food intake with
both diets, eight mice per group were trained for 5 days.
Animals consumed a small portion of standard chow, by
introducing a 1 g pellet into the cage of individually housed
mice at 08:00, following an overnight fast. After 10 min the
leftover pellets were removed. During the training period,
mice were given free access to standard chow from 11:00
to 20:00. On day 5, animals received 500 mg of experimen-
tal diets, low GI or control. Blood samples from the tail
vein (0 min) for measurement of blood glucose were drawn
in the overnight-fasted state. Further blood samples were
drawn only from mice that consumed the whole portion of
the test meals within 5 min (30, 60, 90 and 120 min) and
blood glucose analyses via a glucometer (Optium Xceed,
Abbott Diabetes Care).
Blood processing
Blood was collected from the tail vein into EDTA
coated tubes and samples were centrifuged at 1,200 × g
for 10 min at 4°C. The plasma was then removed and
stored at -80°C. The buffy coat, containing white blood
cells (WBC), was also removed and stored at -80°C until
analysis of DNA damage.
Intraperitoneal glucose tolerance test
Similar to the glycaemic index test, after fasting for 6 h,
animals were anaesthetised with an intraperitoneal injec-
tion of pentobarbitone sodium (100 mg/kg) and a silastic
catheter filled with heparinised saline (20 U/mL) was
inserted into the left carotid artery. Mice also underwenta tracheotomy to aid with breathing. A bolus of glucose
was injected into the intraperitoneal cavity and 200 μL
of blood was sampled at 0, 15, 30, 45, 60, and 90 min for
blood glucose analyses via a glucometer (Optium Xceed,
Abbott Diabetes Care).
Oxidative damage to DNA
Oxidative damage to DNA was assessed by measuring
the number of abasic sites and 8-hydroxy-2-deoxy
guanosine (8-OH-2dG) in WBCs. Genomic DNA was
extracted from the buffy coat using a DNA isolation kit
(Promega). Abasic sites were determined in genomic
DNA from WBC using a DNA damage quantification kit
(Dojindo Molecular Technologies), according to the
manufacturer’s instructions.
An ELISA kit was used to measure the genomic DNA
oxidation byproduct 8-OH-2dG (StressMarq Biosciences).
Each sample was then diluted so that 50 ug of DNA was
used in the 8-OH-2dG assay. The competitive immuno-
assay involves the binding of free 8-OH-2dG to an antibody
coated 96-well plate. The assay and sample concentration
of 8-OH-2dG were carried out as per the manufacturer’s
instructions.
Nucleic acid extraction and preparation for qPCR
Genomic DNA was extracted from frozen quadriceps
muscle using the Bioline ISOLATE Genomic DNA Mini
Kit (Bioline, Australia). DNA and total RNA concentration
was determined spectrophotometrically at 260 nm,
and complimentary DNA (cDNA) was synthesised
from 1 μg RNA using the QIAGEN QuantiTectW
Reverse Transcription Kit following the manufacturer’s
instructions (QIAGEN, Australia).
Telomere length measurement
To measure telomere length in quadriceps muscle, we
used the qPCR method published by Cawthon et al. [63]
with primer sequences modified for telomere measure-
ment in mice by Callicott and Womack [64]. Mouse
telomere primer sequences were as follows: CGG TTT
GTT TGG GTT TGG GTT TGG GTT TGG GTT
TGG GTT and GGC TTG CCT TAC CCT TAC CCT
TAC CCT TAC CCT TAC CCT (50 to 30 forward and
reverse respectively). These primers have been designed
to minimise the formation of primer dimers and are
documented to perform similarly to terminal restriction
fragment length analysis in both mice and humans
[63,64]. The highly conserved acidic ribosomal phospho-
protein PO (36B4) gene was chosen as a single-copy
reference gene; these sequences were as follows: ACT
GGT CTA GGA CCC GAG AAG and TCA ATG GTG
CCT CTG GAG ATT (50 to 30 forward and reverse
respectively). PCR reactions were prepared using
SensiMix SYBR No-ROX master mix (Bioline, Australia)
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ep realplex (Eppendorf, Australia) thermocycler. Fluores-
cence emission data were captured and telomere length
was analysed as described previously [63] and reported as
relative telomere length.
Taqman qPCR assays
Gene expression assays in quadriceps muscle for mTERT
and control 18 s rRNA were prepared using a TaqMan
Gene Expression Master Mix (Applied Biosystems, USA)
specific for each gene following the manufacturer’s instruc-
tions. Reactions were cycled on a MastercyclerW ep
realplex (Eppendorf, Australia) thermocycler, with cycling
conditions as per the manufacturer’s instructions (Applied
Biosystems, USA). To compensate for variations in input
RNA amounts and efficiency of reverse transcription, 18 s
rRNA was quantified and all results were normalised to
these values. Fluorescence emission data were captured
and mRNA levels were analysed using the cycle threshold
value (CT) [65].
Statistical analyses
Statistical analysis was performed using SPSS statistical
package (version 15.0). Results were expressed as mean ±
SEM. Differences were determined by one-way ANOVA
with Tukey HSD as post hoc, or by a Mann-Whitney U test
where appropriate and results were considered statistically
significant if P values ≤0.05.
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